The CC Chemokine CKβ-11/MIP-3β/ELC/Exodus 3 Mediates Tumor Rejection of Murine Breast Cancer Cells Through NK Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The CC Chemokine CKβ-11/MIP-3β/ELC/Exodus 3 Mediates Tumor Rejection of Murine Breast Cancer Cells Through NK Cells

Published:2000-04-15 Issue:8 Volume:164 Page:4025-4031
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Braun Stephen E.,Chen Keyue,Foster Richard G.,Kim Chang H.,Hromas Robert,Kaplan Mark H.,Broxmeyer Hal E.,Cornetta Kenneth

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference56 articles.

1. Cancer statistics, 1995

2. Eight-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast Cancer

3. High-Dose Chemotherapy for Breast Cancer

4. Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma

5. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Cell Migration to Cancer;Cells;2024-05-16

2. Chemokine receptors and their ligands in breast cancer: The key roles in progression and metastasis;International Review of Cell and Molecular Biology;2024

3. Co-infusion of CAR T cells with aAPCs expressing chemokines and costimulatory ligands enhances the anti-tumor efficacy in mice;Cancer Letters;2023-08

4. Does CCL19 act as a double-edged sword in cancer development?;Clinical and Experimental Immunology;2021-12-28

5. Challenges and Recent Advances in NK Cell-Targeted Immunotherapies in Solid Tumors;International Journal of Molecular Sciences;2021-12-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3